Marek Ziobro
Impact in
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 26
- Cancer Immunotherapy and Biomarkers 8
- Cutaneous Melanoma Detection and Management 5
- Cancer Treatment and Pharmacology 5
- CAR-T cell therapy research 4
-
- Melanoma and MAPK Pathways 6
- Co-authors
- Michael B. Atkins (5 shared papers)Piotr Tomczak (5 shared papers)Rodolfo F. Perini (5 shared papers)Rustem Gafanov (5 shared papers)В. Б. Матвеев (5 shared papers)Paweł Wiechno (5 shared papers)Rachel Kloss Silverman (4 shared papers)Frede Donskov (5 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Cancers (2 papers)Melanoma Research (2 papers)Annals of Oncology (2 papers)Acta Oncologica (1 paper)
- Partner nations
- PolandHungaryUnited States
In The Last Decade
Marek Ziobro
38 papers receiving 472 citations
Marek Ziobro's Hit Papers
Peers
Comparison fields: 5 of 48
- Pulmonary and Respiratory Medicine 246
- Oncology 194
- Cancer Research 90
- Molecular Biology 133
- Immunology 31
Countries citing papers authored by Marek Ziobro
This map shows the geographic impact of Marek Ziobro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Ziobro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Ziobro more than expected).
Fields of papers citing papers by Marek Ziobro
This network shows the impact of papers produced by Marek Ziobro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Ziobro. The network helps show where Marek Ziobro may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Ziobro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2021 | 188 |
| 2 | 2019 | 41 | |
| 3 | 2019 | 26 | |
| 4 | 2019 | 25 | |
| 5 | 2012 | 17 | |
| 6 | 2019 | 16 | |
| 7 | 2020 | 15 | |
| 8 | 2019 | 13 | |
| 9 | 2022 | 12 | |
| 10 | 2018 | 11 | |
| 11 | Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer. | 2017 | 11 |
| 12 | 2012 | 10 | |
| 13 | 2020 | 8 | |
| 14 | 2011 | 8 | |
| 15 | 2022 | 7 | |
| 16 | 2024 | 6 | |
| 17 | Effects of palliative treatment with temozolomide in patients with high-grade gliomas. | 2008 | 6 |
| 18 | 2022 | 6 | |
| 19 | 2021 | 6 | |
| 20 | 2022 | 5 |
About Marek Ziobro
Marek Ziobro is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 47 papers that have together received 479 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Renal cell carcinoma treatment (6 papers), Breast Cancer Treatment Studies (6 papers), Melanoma and MAPK Pathways (6 papers), Cutaneous Melanoma Detection and Management (5 papers), Cancer Treatment and Pharmacology (5 papers), Breast Lesions and Carcinomas (5 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (246 citations), Oncology (194 citations), Cancer Research (90 citations), Molecular Biology (133 citations) and Immunology (31 citations). Marek Ziobro has collaborated with scholars based in Poland, Hungary and United States. Frequent co-authors include Michael B. Atkins, Piotr Tomczak, Rodolfo F. Perini, Rustem Gafanov, В. Б. Матвеев, Paweł Wiechno, Rachel Kloss Silverman, Frede Donskov, David F. McDermott and Charles Schloss. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Melanoma Research, Annals of Oncology and Acta Oncologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.